A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
- Joseph I. Clark
- , Jatinder Singh
- , Marc S. Ernstoff
- , Christopher D. Lao
- , Lawrence E. Flaherty
- , Theodore F. Logan
- , Brendan Curti
- , Sanjiv S. Agarwala
- , Bret Taback
- , Lee Cranmer
- , Jose Lutzky
- , Theresa L. Luna
- , Sandra Aung
- , David H. Lawson
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations
19
Downloads
(Pure)